Hims & Hers Health (HIMS) Prepaid Assets (2019 - 2026)
Hims & Hers Health (HIMS) reported Prepaid Assets of $65.8 million for Q1 2026, up 36.51% on a YoY basis from $48.2 million in Q1 2025, and up 1404.23% sequentially from $4.4 million in Q4 2025.
Hims & Hers Health (HIMS) Prepaid Assets (2019 - 2026) Analysis & Trends
Hims & Hers Health (HIMS) has 8 years of Prepaid Assets data on file, last reported at $65.8 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 36.51% year-over-year to $65.8 million; the trailing twelve-month figure through Mar 2026 stood at $65.8 million (up 36.51% YoY), and the FY2025 full-year result was $4.4 million, down 85.96% from the prior year.
- Prepaid Assets improved to $65.8 million in Q1 2026, from $4.4 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $109.5 million in Q3 2025 to a low of $800000.0 in Q2 2022.
- A 5-year average of $24.2 million and a median of $16.8 million in 2022 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets jumped 3709.52% in 2022 and tumbled 88.45% in 2023, its largest moves.
- Tracing HIMS's Prepaid Assets over 5 years: stood at $15.4 million in 2022, then slumped by 72.77% to $4.2 million in 2023, then surged by 642.62% to $31.2 million in 2024, then plunged by 85.96% to $4.4 million in 2025, then jumped by 1404.23% to $65.8 million in 2026.
- Business Quant data shows HIMS's Prepaid Assets at $65.8 million in Q1 2026, $4.4 million in Q4 2025, and $109.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn |
| 10 | Hims & Hers Health | 6.44 Bn | 5.69 Bn | 396.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 65.80 Mn |
| Dec 31, 2025 | 4.37 Mn |
| Sep 30, 2025 | 109.53 Mn |
| Jun 30, 2025 | 20.56 Mn |
| Mar 31, 2025 | 48.20 Mn |
| Dec 31, 2024 | 31.15 Mn |
| Sep 30, 2024 | 23.19 Mn |
| Jun 30, 2024 | 3.29 Mn |
| Mar 31, 2024 | 28.32 Mn |
| Dec 31, 2023 | 4.20 Mn |
| Sep 30, 2023 | 15.73 Mn |
| Jun 30, 2023 | 20.09 Mn |
| Mar 31, 2023 | 1.93 Mn |
| Dec 31, 2022 | 15.41 Mn |
| Sep 30, 2022 | 1.94 Mn |
| Jun 30, 2022 | 800,000.00 |
| Mar 31, 2022 | 16.75 Mn |
| Dec 31, 2021 | 890,000.00 |
| Sep 30, 2021 | 10.95 Mn |
| Jun 30, 2021 | 21,000.00 |